🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Infants born with heart problems are at risk of developing gut disease due ...
Status
Completed
Location
Great Ormond Street Hospital
Start Date
2018-05-01
Trial ID
NCT03255564
Treatments Being Tested
This randomized phase II trial studies how well nivolumab or expectant obse...
Status
Withdrawn
Location
Alliance for Clinical Trials in Oncology
Start Date
2017-11-03
Trial ID
NCT03220009
The purpose of this research study is to evaluate a new drug pembrolizumab ...
Status
Unknown
Location
Stanford Cancer Institute
Start Date
2017-11-09
Trial ID
NCT03226249
High-risk screening for Gaucher disease and Acid Sphingomyelinase Deficienc...
Status
Not Yet Recruiting
Location
China Medical University Hospita
Start Date
2024-05-01
Trial ID
NCT06258577
This laboratory study is looking into biomarkers in samples from younger pa...
Status
Withdrawn
Location
Childrens Oncology Group
Start Date
2012-08-22
Trial ID
NCT01642095
Treatments Being Tested
RATIONALE: Studying samples of tumor tissue from patients with cancer in th...
Status
Unknown
Location
Leeds Cancer Centre at St. James's University Hospital
Start Date
2007-01
Trial ID
NCT00897481
This phase I trial studies the side effects and best dose of wee1 kinase in...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-05-25
Trial ID
NCT02791919
Phase I trial to study the effectiveness of oblimersen plus combination che...
Status
Completed
Location
Children's Oncology Group
Start Date
2002-11
Trial ID
NCT00039481
This clinical trial studies the physiology and immunology of new-onset post...
Status
Terminated
Location
Vanderbilt-Ingram Cancer Center
Start Date
2014-11-20
Trial ID
NCT02240381
Tumours continually shed DNA into the circulation, where it can be accessed...
Status
Completed
Location
Antoni van Leeuwenhoek
Start Date
2018-07-16
Trial ID
NCT03540563
Treatments Being Tested